BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Converso TR, Assoni L, André GO, Darrieux M, Leite LCC. The long search for a serotype independent pneumococcal vaccine. Expert Rev Vaccines 2020;19:57-70. [PMID: 31903805 DOI: 10.1080/14760584.2020.1711055] [Cited by in Crossref: 16] [Cited by in F6Publishing: 13] [Article Influence: 8.0] [Reference Citation Analysis]
Number Citing Articles
1 Rojas Converso T, Goulart C, Rodriguez D, Guerra MES, Darrieux M, Leite LCC. Immune response induced in mice by a hybrid rPotD-PdT pneumococcal protein. PLoS ONE 2022;17:e0273017. [DOI: 10.1371/journal.pone.0273017] [Reference Citation Analysis]
2 Passaris I, Mauder N, Kostrzewa M, Burckhardt I, Zimmermann S, van Sorge NM, Slotved HC, Desmet S, Ceyssens PJ. Validation of Fourier Transform Infrared Spectroscopy for Serotyping of Streptococcus pneumoniae. J Clin Microbiol 2022;:e0032522. [PMID: 35699436 DOI: 10.1128/jcm.00325-22] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
3 Pawlowski A, Lannergård J, Gonzalez-Miro M, Cao D, Larsson S, Persson JJ, Kitson G, Darsley M, Rom AL, Hedegaard M, Fischer PB, Johansson-Lindbom B. A group B Streptococcus alpha-like protein subunit vaccine induces functionally active antibodies in humans targeting homotypic and heterotypic strains. Cell Rep Med 2022;3:100511. [PMID: 35243418 DOI: 10.1016/j.xcrm.2022.100511] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
4 Tokarskaya MM, Nayаnova EA, Nechaeva OV, Baranovskaya SA, Afanacyeva OM, Vorobyev DS, Gruber IM, Astashkina EA, Ovechko NN, Semenova IB, Yastrebova NE. Immunobiological Properties of Antigenic Preparations Streptococcus pneumoniae and their Mixtures. Epidemiology and Vaccinal Prevention 2022;20:5-11. [DOI: 10.31631/2073-3046-2021-20-6-5-11] [Reference Citation Analysis]
5 Wang Y, Xia L, Wang G, Lu H, Wang H, Luo S, Zhang T, Gao S, Huang J, Min X. Subcutaneous immunization with the fusion protein ΔA146Ply-SP0148 confers protection against Streptococcus pneumoniae infection. Microb Pathog 2021;162:105325. [PMID: 34848296 DOI: 10.1016/j.micpath.2021.105325] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
6 Du QQ, Shi W, Yu D, Yao KH. Epidemiology of non-vaccine serotypes of Streptococcus pneumoniae before and after universal administration of pneumococcal conjugate vaccines. Hum Vaccin Immunother 2021;:1-10. [PMID: 34726580 DOI: 10.1080/21645515.2021.1985353] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
7 Assoni L, Girardello R, Converso TR, Darrieux M. Current Stage in the Development of Klebsiella pneumoniae Vaccines. Infect Dis Ther 2021;10:2157-75. [PMID: 34476772 DOI: 10.1007/s40121-021-00533-4] [Cited by in Crossref: 10] [Cited by in F6Publishing: 7] [Article Influence: 10.0] [Reference Citation Analysis]
8 André GO, Borges MT, Assoni L, Ferraz LFC, Sakshi P, Adamson P, Gordon DL, Ogunniyi AD, Venter H, Converso TR, Darrieux M. Protective role of PhtD and its amino and carboxyl fragments against pneumococcal sepsis. Vaccine 2021;39:3626-32. [PMID: 34045100 DOI: 10.1016/j.vaccine.2021.04.068] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 3.0] [Reference Citation Analysis]
9 Scelfo C, Menzella F, Fontana M, Ghidoni G, Galeone C, Facciolongo NC. Pneumonia and Invasive Pneumococcal Diseases: The Role of Pneumococcal Conjugate Vaccine in the Era of Multi-Drug Resistance. Vaccines (Basel) 2021;9:420. [PMID: 33922273 DOI: 10.3390/vaccines9050420] [Cited by in Crossref: 5] [Cited by in F6Publishing: 6] [Article Influence: 5.0] [Reference Citation Analysis]
10 Wall EC, Chan JM, Gil E, Heyderman RS. Acute bacterial meningitis. Curr Opin Neurol 2021;34:386-95. [PMID: 33767093 DOI: 10.1097/WCO.0000000000000934] [Cited by in Crossref: 6] [Cited by in F6Publishing: 9] [Article Influence: 6.0] [Reference Citation Analysis]
11 Amin-Chowdhury Z, Groves N, Sheppard CL, Litt D, Fry NK, Andrews N, Ladhani SN. Invasive pneumococcal disease due to 22F and 33F in England: A tail of two serotypes. Vaccine 2021;39:1997-2004. [PMID: 33715901 DOI: 10.1016/j.vaccine.2021.02.026] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 7.0] [Reference Citation Analysis]
12 Ness S, Hilleringmann M. Streptococcus pneumoniae Type 1 Pilus - A Multifunctional Tool for Optimized Host Interaction. Front Microbiol 2021;12:615924. [PMID: 33633703 DOI: 10.3389/fmicb.2021.615924] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
13 Su T, Nakamoto R, Chun YY, Chua WZ, Chen JH, Zik JJ, Sham LT. Decoding capsule synthesis in Streptococcus pneumoniae. FEMS Microbiol Rev 2020:fuaa067. [PMID: 33338218 DOI: 10.1093/femsre/fuaa067] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 2.0] [Reference Citation Analysis]
14 Assoni L, Milani B, Carvalho MR, Nepomuceno LN, Waz NT, Guerra MES, Converso TR, Darrieux M. Resistance Mechanisms to Antimicrobial Peptides in Gram-Positive Bacteria. Front Microbiol 2020;11:593215. [PMID: 33193264 DOI: 10.3389/fmicb.2020.593215] [Cited by in Crossref: 20] [Cited by in F6Publishing: 20] [Article Influence: 10.0] [Reference Citation Analysis]
15 Feldman C, Anderson R. Recent advances in the epidemiology and prevention of Streptococcus pneumoniae infections. F1000Res 2020;9:F1000 Faculty Rev-338. [PMID: 32411353 DOI: 10.12688/f1000research.22341.1] [Cited by in Crossref: 21] [Cited by in F6Publishing: 22] [Article Influence: 10.5] [Reference Citation Analysis]